Evidence map›Paper›PMID 26785769›Full record

ArticleScientific reports2016

Pilot study of a rapid and minimally instrumented sputum sample preparation method for molecular diagnosis of tuberculosis.

Tanya M Ferguson, Kris M Weigel, Annie Lakey Becker, Delia Ontengco, Masahiro Narita, Ilya Tolstorukov, Robert Doebler, Gerard A Cangelosi, Angelika Niemz

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. EliminateJournal of medical microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tanya M FergusonClaremont BioSolutions, LLC, Upland, CA.
Kris M WeigelUniversity of Washington, Department of Environmental and Occupational Health Sciences, Seattle, WA.
Annie Lakey BeckerUniversity of Washington, Department of Environmental and Occupational Health Sciences, Seattle, WA.
Delia OntengcoSeattle Biomedical Research Institute, Seattle, WA.
Masahiro NaritaPublic Health - Seattle &King County, TB Control Program, Seattle, WA.
Ilya TolstorukovKeck Graduate Institute of Applied Life Sciences, Claremont, CA.
Robert DoeblerClaremont BioSolutions, LLC, Upland, CA.
Gerard A CangelosiUniversity of Washington, Department of Environmental and Occupational Health Sciences, Seattle, WA.
Angelika NiemzKeck Graduate Institute of Applied Life Sciences, Claremont, CA.

Funding

Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic AcidR01AI090831 · NIAID · KECK GRADUATE INST OF APPLIED LIFE SCIS · PI NIEMZ, ANGELIKA · 2010 to 2013
$3.5M
NIAID NIH HHS R01 AI090831
6 · The paper itself

Abstract

Nucleic acid amplification testing (NAAT) enables rapid and sensitive diagnosis of tuberculosis (TB), which facilitates treatment and mitigates transmission. Nucleic acid extraction from sputum constitutes the greatest technical challenge in TB NAAT for near-patient settings. This report presents preliminary data for a semi-automated sample processing method, wherein sputum is disinfected and liquefied, followed by PureLyse(®) mechanical lysis and solid-phase nucleic acid extraction in a miniaturized, battery-operated bead blender. Sputum liquefaction and disinfection enabled a >10(4) fold reduction in viable load of cultured Mycobacterium tuberculosis (M.tb) spiked into human sputum, which mitigates biohazard concerns. Sample preparation via the PureLyse(®) method and a clinically validated manual method enabled positive PCR-based detection for sputum spiked with 10(4) and 10(5) colony forming units (cfu)/mL M.tb. At 10(3) cfu/mL sputum, four of six and two of six samples amplified using the comparator and PureLyse(®) method, respectively. For clinical specimens from TB cases and controls, the two methods provided 100% concordant results for samples with 1 mL input volume (N = 41). The semi-automated PureLyse(®) method therefore performed similarly to a validated manual comparator method, but is faster, minimally instrumented, and can be integrated into TB molecular diagnostic platforms designed for near-patient low-resource settings.

Indexed as

Mycobacterium tuberculosisHumansNucleic Acid Amplification TechniquesReal-Time Polymerase Chain ReactionReproducibility of ResultsSputumTuberculosisTuberculosis, Pulmonary

Identifiers

PMID26785769
PMCPMC4726292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.